Meeting
2017 Gastrointestinal Cancers Symposium
Analysis of outcomes in metastatic pancreatic cancer: Real-world experience in academic cancer centers.
Authors
Elizabeta C. Popa
Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY
Elizabeta C. Popa , Emma Rabinovich , Davendra Sohal , Kathryn Cecilia Arbour , Timothy Suyong Kim , Yao Lu , Paul J. Christos , Alok A. Khorana , Manish A. Shah
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 35, 2017 (suppl 4S; abstract 458)
DOI
10.1200/JCO.2017.35.4_suppl.458
Abstract #
458
Poster Bd #
L20
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world overall survival and time to next treatment in patients with metastatic pancreatic ductal adenocarcinoma who received FOLFIRINOX and modified FOLFIRINOX in the first line.
First Author: Syvart Dennen
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Adjuvant modified FOLFIRINOX (mFFX) for resected pancreatic cancer (PDAC): Real world outcomes (RWO).
First Author: Fergus Keane
Poster
2019 Gastrointestinal Cancers Symposium
Real world usage of gemcitabine and nabpaclitaxel in older adults with metastatic pancreatic cancer: A single institution experience.
First Author: Arthur Winer
Poster
2018 Gastrointestinal Cancers Symposium
Retrospective single center review of toxicity and efficacy of a modified FOLFIRINOX regimen in patients with locally advanced and metastatic pancreatic cancer.
First Author: Bhargavi Pulluri